Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Ullman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|September 25, 2013
The application of next generation sequencing to the understanding of antibody repertoiresPascale Mathonet, Christopher G Ullman
Frontiers in Chemistry|January 7, 2016
Recent Advances Toward the Discovery of Drug-Like Peptides De novoMichael Goldflam, Christopher G Ullman
Future Medicinal Chemistry|December 23, 2014
Library construction, selection and modification strategies to generate therapeutic peptide-based modulators of protein-protein interactionsDaniel Baxter, Christopher G Ullman, Jody M Mason
Briefings in Functional Genomics|June 2, 2011
In vitro methods for peptide display and their applicationsChristopher G Ullman, Laura Frigotto, R Neil Cooley
ACS Chemical Biology|September 8, 2017
Exploiting Overlapping Advantages of In Vitro and In Cellulo Selection Systems to Isolate a Novel High-Affinity cJun AntagonistDaniel Baxter, Christopher G Ullman, Laura Frigotto, et al.
Protein Engineering, Design & Selection : PEDS|February 5, 2013
Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS displaySeema Patel, Pascale Mathonet, Agnes M Jaulent, et al.
Protein Engineering, Design & Selection : PEDS|September 17, 2009
An in vitro selection strategy for conferring protease resistance to ligand binding peptidesBill Eldridge, R Neil Cooley, Richard Odegrip, et al.
Scientific Reports|February 1, 2019
A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations: implications for peptide-based analgesicsAndrew J Poole, Laura Frigotto, Matthew E Smith, et al.
Biochemical Society Transactions|September 25, 2013
ProxiMAX randomization: a new technology for non-degenerate saturation mutagenesis of contiguous codonsMohammed Ashraf, Laura Frigotto, Matthew E Smith, et al.
Scientific Reports|May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancersHye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|September 25, 2013
The application of next generation sequencing to the understanding of antibody repertoiresPascale Mathonet, Christopher G Ullman
Frontiers in Chemistry|January 7, 2016
Recent Advances Toward the Discovery of Drug-Like Peptides De novoMichael Goldflam, Christopher G Ullman
Future Medicinal Chemistry|December 23, 2014
Library construction, selection and modification strategies to generate therapeutic peptide-based modulators of protein-protein interactionsDaniel Baxter, Christopher G Ullman, Jody M Mason
Briefings in Functional Genomics|June 2, 2011
In vitro methods for peptide display and their applicationsChristopher G Ullman, Laura Frigotto, R Neil Cooley
ACS Chemical Biology|September 8, 2017
Exploiting Overlapping Advantages of In Vitro and In Cellulo Selection Systems to Isolate a Novel High-Affinity cJun AntagonistDaniel Baxter, Christopher G Ullman, Laura Frigotto, et al.
Protein Engineering, Design & Selection : PEDS|February 5, 2013
Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS displaySeema Patel, Pascale Mathonet, Agnes M Jaulent, et al.
Protein Engineering, Design & Selection : PEDS|September 17, 2009
An in vitro selection strategy for conferring protease resistance to ligand binding peptidesBill Eldridge, R Neil Cooley, Richard Odegrip, et al.
Scientific Reports|February 1, 2019
A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations: implications for peptide-based analgesicsAndrew J Poole, Laura Frigotto, Matthew E Smith, et al.
Biochemical Society Transactions|September 25, 2013
ProxiMAX randomization: a new technology for non-degenerate saturation mutagenesis of contiguous codonsMohammed Ashraf, Laura Frigotto, Matthew E Smith, et al.
Scientific Reports|May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancersHye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
Pageof 2